Parental substance use disorder linked to greater risk of intellectual disability in children

NewsGuard 100/100 Score

Children of a parent with alcohol or drug use disorder have a greater risk of intellectual disability, even if the problem only lies with the father, researchers from Karolinska Institutet in Sweden report. According to the study, which is published in the journal eClinicalMedicine, preventive measures should be directed at both parents.

It is well known that a woman's alcohol consumption during pregnancy can increase the risk of her child developing an intellectual disability. Research from Karolinska Institutet now shows that all forms of substance abuse, both in the mother and the father, and not only during pregnancy, can constitute a risk factor.

Have mainly focused on mothers

Preventative measures, such as educating healthcare professionals and public health recommendations, have focused for decades on mothers with alcohol-related problems. Our findings highlight the importance of also directing such measures towards fathers with different types of substance use disorder."

Lotfi Khemiri, Researcher, Departments of Medical Epidemiology and Biostatistics and Clinical Neuroscience, Karolinska Institutet

The study, which is based on data from Swedish registries, comprised almost two million babies born between 1978 and 2002 and their parents. The researchers found that 1.2 per cent of babies born to parents without such a disorder were diagnosed with an intellectual disability, compared with 3 per cent of the babies who had one parent with a diagnosis related to a substance use disorder (alcohol or drug abuse).

Higher risk before birth

The elevated risk was greater if the parent had received a diagnosis before or during pregnancy rather than after birth. A substance use disorder diagnosis registered before birth was associated with more than twice the risk of intellectual disability in the baby, regardless of which parent had the diagnosis. The correlation was weaker but still statistically significant after adjustment of socioeconomic factors and psychiatric comorbidity in the parents.

"Since it was an observational study, we can draw no conclusions about the underlying mechanism, but we suspect that both genetic and environmental factors, including harmful effects of substance abuse on foetal development, may play a part," says Dr Khemiri. "We hope that the results will contribute to the preventative efforts, as well as to the improved diagnosis of children with an intellectual disability and to timely intervention directed both to the child as well as parents in need of substance use disorder treatment."

Alcohol is a major risk factor

Intellectual disability was observed to be much more likely in alcohol-related problems during pregnancy, where the risk was five and three times higher depending on whether it was the mother or father who had the alcohol use disorder diagnosis.

The study was financed by several bodies, primarily Region Stockholm, Systembolaget (the Swedish government alcohol retail monopoly) and the Fredrik and Ingrid Thuring Foundation. Co-author and KI researcher Henrik Larsson has received research grants from Shire/Takeda and fees from Medice, Shire/Takeda and Evolan Pharma AB, although unconnected to this present study.

Source:
Journal reference:

Khemiri, L., et al. (2023). Parental substance use disorder and risk of intellectual disability in offspring in Sweden: a national register study. eClinicalMedicine. doi.org/10.1016/j.eclinm.2023.102170.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients